A Lasix, Frusemide, Furosemide CEP of the European Pharmacopoeia monograph is often referred to as a Lasix, Frusemide, Furosemide Certificate of Suitability (COS). The purpose of a Lasix, Frusemide, Furosemide CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Lasix, Frusemide, Furosemide EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Lasix, Frusemide, Furosemide to their clients by showing that a Lasix, Frusemide, Furosemide CEP has been issued for it. The manufacturer submits a Lasix, Frusemide, Furosemide CEP (COS) as part of the market authorization procedure, and it takes on the role of a Lasix, Frusemide, Furosemide CEP holder for the record. Additionally, the data presented in the Lasix, Frusemide, Furosemide CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Lasix, Frusemide, Furosemide DMF.
A Lasix, Frusemide, Furosemide CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Lasix, Frusemide, Furosemide CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Lasix, Frusemide, Furosemide suppliers with CEP (COS) on PharmaCompass.